These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3797807)

  • 1. Effects of starvation on guanidino compound metabolism in mice.
    Shindo S; Watanabe Y; Mori A
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):73-85. PubMed ID: 3797807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP; Macdonald RL
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
    Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
    Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
    Levillain O; Marescau B; Possemiers I; De Deyn P
    Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic pathway of guanidino compounds in chronic renal failure.
    Mikami H; Orita Y; Ando A; Fujii M; Kikuchi T; Yoshihara K; Okada A; Abe H
    Adv Exp Med Biol; 1982; 153():449-58. PubMed ID: 7164918
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal handling of guanidino compounds in rat and rabbit.
    Levillain O; Marescau B; De Deyn PP
    J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanidino compounds generate reactive oxygen species.
    Mori A; Kohno M; Masumizu T; Noda Y; Packer L
    Biochem Mol Biol Int; 1996 Sep; 40(1):135-43. PubMed ID: 8886279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biosynthesis of guanidinosuccinic acid by perfused rat liver.
    Perez G; Rey A; Schiff E
    J Clin Invest; 1976 Mar; 57(3):807-9. PubMed ID: 1249211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanidino compounds in serum and brain of audiogenically sensitive rats.
    Wiechert P; Marescau B; De Deyn P; Lowenthal A
    Biomed Biochim Acta; 1986; 45(10):1339-42. PubMed ID: 3566723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanidino compounds and hemodialysis.
    Ochiai Y; Abe S; Yamada T; Tada K; Kosaka F
    Adv Exp Med Biol; 1982; 153():459-64. PubMed ID: 7164919
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the precursor of methylguanidine in rats with renal failure.
    Yokozawa T; Fujitsuka N; Oura H
    Nephron; 1991; 58(1):90-4. PubMed ID: 1857486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis.
    Eloot S; van Biesen W; Dhondt A; de Smet R; Marescau B; De Deyn PP; Verdonck P; Vanholder R
    Nephrol Dial Transplant; 2009 Jul; 24(7):2225-32. PubMed ID: 19225018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo.
    Nagase S; Aoyagi K; Narita M; Tojo S
    Nephron; 1985; 40(4):470-5. PubMed ID: 4022219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
    Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
    Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition.
    Torremans A; Marescau B; Kränzlin B; Gretz N; Billiouw JM; Vanholder R; De Smet R; Bouwman K; Brouns R; De Deyn PP
    Kidney Int; 2006 Jun; 69(11):2003-12. PubMed ID: 16641922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and histopathological changes in nephrectomized mice.
    Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP
    Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R; Pei YQ; Marescau B; De Deyn PP
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency.
    Torremans A; Marescau B; Possemiers I; Van Dam D; D'Hooge R; Isbrandt D; De Deyn PP
    J Neurol Sci; 2005 Apr; 231(1-2):49-55. PubMed ID: 15792821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.